Advertisement
BOSTON, Aug. 06, 2018 /PRNewswire-PRWeb/ -- On June 1, 2018 Saphena Medical Inc. was awarded a group purchasing agreement as a Breakthrough Technology with Premier, a national healthcare improvement company. Saphena Medical's Venapax® Endoscopic Vessel Harvesting System is the first unitary EVH system on the market that allows for the saphenous vein or radial artery to be harvested for a coronary artery bypass graft procedure in a single comprehensive system. This agreement gives Premier members access to pre-negotiated pricing for the Venapax® system.
"This partnership with Premier is extremely pivotal for our company," says Michael J. Glennon, CEO and Director of Saphena Medical. "We're very excited to have the opportunity to offer lower-cost access to our state-of-the-art Venapax® EVH System, which allows hospitals and doctors to continue delivering safe, lifesaving, effective patient care while maintaining cost control," Glennon adds.
The new agreement will afford doctors and hospitals lower-cost and improved access to Venapax® for use during endoscopic vein harvesting procedures. Venapax® is a single comprehensive solution for endoscopic vein harvesting in the cardiovascular arena.
ABOUT SAPHENA MEDICAL Saphena Medical is a Boston, Massachusetts-based medical device company established in 2013. Its team has deep knowledge in the cardiovascular space, coupled with advanced medical device design and innovation. In 2015, Saphena marketed its first cardiovascular device, the Venapax® Endoscopic Vessel Harvesting System, which consolidates EVH into a single tool.
Michael J. Glennon has been CEO and a Director of Saphena Medical since February 2013.
SOURCE Saphena Medical, Inc.
Advertisement
"This partnership with Premier is extremely pivotal for our company," says Michael J. Glennon, CEO and Director of Saphena Medical. "We're very excited to have the opportunity to offer lower-cost access to our state-of-the-art Venapax® EVH System, which allows hospitals and doctors to continue delivering safe, lifesaving, effective patient care while maintaining cost control," Glennon adds.
The new agreement will afford doctors and hospitals lower-cost and improved access to Venapax® for use during endoscopic vein harvesting procedures. Venapax® is a single comprehensive solution for endoscopic vein harvesting in the cardiovascular arena.
ABOUT SAPHENA MEDICAL Saphena Medical is a Boston, Massachusetts-based medical device company established in 2013. Its team has deep knowledge in the cardiovascular space, coupled with advanced medical device design and innovation. In 2015, Saphena marketed its first cardiovascular device, the Venapax® Endoscopic Vessel Harvesting System, which consolidates EVH into a single tool.
Michael J. Glennon has been CEO and a Director of Saphena Medical since February 2013.
SOURCE Saphena Medical, Inc.
